Glen Harbor Capital Management’s Idexx Laboratories IDXX Stock Holding History

Glen Harbor Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.15M	Sell	4,216 -306	-7%	-$85.2K	0.02%	443
2019 Q2	$1.25M	Sell	4,522 -2,958	-40%	-$729K	0.03%	423
2019 Q1	$1.67M	Buy	7,480 +782	+12%	+$161K	0.04%	345
2018 Q4	$1.25M	Buy	6,698 +1,530	+30%	+$314K	0.03%	385
2018 Q3	$1.29M	Sell	5,168 -408	-7%	-$99K	0.03%	422
2018 Q2	$1.22M	Sell	5,576 -646	-10%	-$133K	0.03%	390
2018 Q1	$1.19M	Sell	6,222 -2,720	-30%	-$502K	0.03%	380
2017 Q4	$1.4M	Sell	8,942 -6,698	-43%	-$1.05M	0.03%	363
2017 Q3	$2.43M	Buy	15,640 +1,224	+8%	+$194K	0.06%	269
2017 Q2	$2.33M	Buy	14,416 +6,528	+83%	+$1.06M	0.06%	266
2017 Q1	$1.22M	Buy	7,888 +1,632	+26%	+$225K	0.03%	376
2016 Q4	$734K	Buy	+6,256	New	+$714K	0.02%	417

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Glen Harbor Capital Management's IDXX Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Idexx Laboratories (IDXX) stake by 6.8% in Q3 2019, selling an estimated $85.2K and leaving 4,216 shares worth $1.15M. The position accounts for 0.02% of the portfolio, ranked #443.

Glen Harbor Capital Management first reported a position in IDXX in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.43M in Q3 2017. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

Glen Harbor Capital Management held 4,216 shares of Idexx Laboratories worth $1.15M as of Q3 2019.
Glen Harbor Capital Management sold 306 Idexx Laboratories shares in Q3 2019, an estimated $85.2K.
Idexx Laboratories made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #443 holding.
Glen Harbor Capital Management first reported a position in Idexx Laboratories in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Idexx Laboratories position peaked at $2.43M in Q3 2017.
720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.